Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10

Zhiqiang Qin1, Patricia Kearney, Karlie Plaisance

  • 1Department of Medicine, Hollings Cancer Center, Medical University of South Carolina,Charleston, South Carolina, USA.

Insights

Kaposi sarcoma-associated herpesvirus (KSHV) encoded microRNAs reprogram macrophages to secrete tumor-promoting cytokines like IL-6 and IL-10. This reprogramming involves targeting the C/EBPbeta transcription factor, driving KSHV-driven cancer progression.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • Macrophages are key immune cells that can either fight or promote tumors.
  • In KSHV-associated cancers, macrophages may contribute to tumor growth by secreting specific cytokines.
  • The precise role of KSHV-infected macrophages in shaping the tumor microenvironment's cytokine profile remains unclear.

Purpose of the Study:

  • To investigate how KSHV-encoded microRNAs influence macrophage cytokine secretion.
  • To determine the molecular mechanisms by which KSHV miRNAs affect cytokine production in macrophages.
  • To elucidate the role of KSHV-driven macrophage reprogramming in KSHV-associated tumorigenesis.

Main Methods:

  • Utilized murine macrophages and human myelomonocytic cells to study KSHV miRNA effects.
  • Employed bioinformatics to identify miRNA binding sites on target genes.
  • Performed immunoblot analyses to assess protein expression changes.
  • Used RNA interference to validate the role of specific protein isoforms.

Main Results:

  • KSHV microRNAs (miRNAs) were found to induce secretion of IL-6 and IL-10 in macrophages.
  • Bioinformatics and immunoblotting revealed KSHV miRNAs target C/EBPbeta transcription factor, specifically reducing the inhibitory isoform LIP.
  • Targeting LIP directly led to increased IL-6 and IL-10 secretion by macrophages.

Conclusions:

  • KSHV miRNAs play a significant role in programming macrophage cytokine responses.
  • This reprogramming favors the secretion of pro-tumorigenic cytokines (IL-6, IL-10) by macrophages.
  • These findings highlight a mechanism by which KSHV promotes cancer progression through macrophage manipulation.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...